| [1］ Graus F，Saiz A，Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS［J］. J Neurol，2010，257：509-517. [2］ 张华，母艳蕾. 自身免疫性脑炎临床鉴别诊断［J］. 中国实用内科杂志，2012，32（11）：835-838. [3］ Dalmau J，Tuzun E，Wu HY，et al. Paraneoplastic anti-N-methyl-Daspartate receptor encephalitis associated with ovarian teratoma［J］. Ann Neurol，2007，61：25-36. [4］ Irani SR，Vincent A，Schott JM. Autoimmune encephalitis［J］. BMJ，2011，342：1917-1918. [5］ Dalmau J，Gleichman AJ，Hughes EG，et al. Anti-NMDA receptor encephalitis：case series and analysis of the effects of antibodies［J］. Lancet Neurol，2008，7：1091-1098. [6］ Granerod J，Ambrose HE，Davies NW，et al. Causes of encephalitis and differences in their clinical presentations in England：a multicentre， population-based prospective study［J］. Lancet Infect Dis，2010，10：835-844. [7］ Gable MS，Sheriff H，Dalmau J，et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project［J］. Clin Infect Dis，2012，54（7）：899-904. [8］ Florance NR，Davis RL，Lam C，et al. Anti-N-methyl-D-aspartate receptor （NMDAR） encephalitis in children and adolescents［J］. Ann Neurol，2009，66：11-18. [9］ Armangue T，Titulaer MJ， Ignacio M，et al. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients［J］. J Pediatr，2013，162（4）：850-856. [10］ Dalmau J，Tfiztin E，Wu HY，et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma［J］. Ann Neurol，2007，61：25-36. [11］ Dalmau J，Lancaster E，Martinez-Hernandez E，et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis［J］. Lancet Neurol，2011，10（1）：63-74. [12］ Titulaer MJ，McCracken L，Gabilondo I，et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis：an observational cohort study［J］. Lancet Neurol，2013，12（2）：157-165. [13］ Irani SR，Bera K，Waters P，et al. N-methyl-D-aspartate antibody encephalitis： temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes［J］. Brain，2010，133：1655-1667. [14］ Titulaer MJ，Dalmau J. Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men［J］. Neurology，2014，82(7):550-551. [15］ Schmitt SE，Pargeon K，Frechette ES，et al. Extreme delta brush：a unique EEG pattern in adults with anti-NMDA receptor encephalitis［J］. Neurology，2012，79（11）：1094-1100. [16］ Luca N，Daengsuwan T，Dalmau J，et al. Anti-N-methyl-D-aspartate receptor encephalitis： a newly recognized inflammatory brain disease in children［J］. Arthritis Rheum，2011，63：2516-2522. [17］ Wong-Kisiel LC，Ji T，Renaud DL，et al. Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis［J］. Neurology，2010，74：1550-1551. [18］ Kashyape P，Taylor E，Ng J，et al. Successful treatment of two paediatric cases of anti- NMDA receptor encephalitis with cyclophosphamide：the need for early aggressive immunotherapy in tumour negative paediatric patients［J］. Eur J Paediatr Neurol，2012，16：74-78. [19］ Mitani T，Ohtsuka Y，Yamamoto K，et al. An 8-year-old boy with anti-NMDA receptor encephalitis， successfully treated with cyclophosphamide［J］. No To Hattatsu，2013，45（1）：53-57. [20］ Titulaer MJ，Kayser MS，Dalmau J. Prevalence and treatment of anti-NMDA receptor encephalitis - authors' reply［J］. Lancet Neurol，2013，12（5）：424-425. [21］ Irani SR，Vincent A. NMDA receptor antibody encephalitis［J］. Curr Neurol Neurosci Rep，2011，11（3）：298-304. [22］ McKeon A. The importance of early and sustained treatment of a common autoimmune encephalitis［J］. Lancet Neurol，2013，12（2）：123-125. [23］ Buckley C， Clover OJ ，Tüzün EL，et al. Potassium channel antibodies in two patients with reversible limbic encephalitis［J］. Ann Neurol，2001，50（1）：73-78 . [24］ Irani SR，Alexander S，Waters P，et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich，glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis，Morvan's syndrome and acquired neuromyotonia［J］. Brain，2010，133（9）：2734-2748 . [25］ Schulte U，Thumfart JO，Klöcker N，et al. The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1［J］. Neuron，2006，49（5）：697-706. [26］ Irani SR，Michell AW，Lang B，et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis［J］. Ann Neurol，2011，69（5）：892-900. [27］ Strauss KA，Puffenberger EG，Huentelman MJ，et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2［J］. N Engl J Med，2006，354（13）：1370-1377. [28］ Lai M，Huijbers MG，Lancaster E，et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels：a case series［J］. Lancet Neurol，2010，9：776-785. [29］ Suleiman J，Brilot F，Lang B，et al. Autoimmune epilepsy in children： case series and proposed guidelines for identification［J］. Epilepsia，2013，54（6）：1036-1045. [30］ Sakuma H，Sugai K，Sasaki M. Acute nonparaneoplastic limbic encephalitis in childhood： a case series in Japan［J］. Pediatr Neurol，2010，43（3）：167-172. [31］ Haberlandt E，Bast T，Ebner A，et al. Limbic encephalitis in children and adolescents［J］. Arch Dis Child，2011，96（2）：186-191. [32］ Bataller L，Kleopa KA，Dalmau J，et al. Autoimmune limbic encephalitis in 39 patients： immunophenotypes and outcomes［J］. J Neurol Neurosurg Psychiatry，2007，78：381-385. [33］ Asztely F，Kumlien E. The diagnosis and treatment of limbic encephalitis［J］. Acta Neurol Scand，2012， 126（6）： 365-375. |
